S576-0944 Screening compound: 2-(4-{1-[1-(2-METHOXYETHYL)-6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL]PYRROLIDINE-3-CARBONYL}PIPERAZIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE

S576-0944 Screening compound: 2-(4-{1-[1-(2-METHOXYETHYL)-6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL]PYRROLIDINE-3-CARBONYL}PIPERAZIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE
S576-0944 Screening compound: 2-(4-{1-[1-(2-METHOXYETHYL)-6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL]PYRROLIDINE-3-CARBONYL}PIPERAZIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound S576-0944
2-(4-{1-[1-(2-METHOXYETHYL)-6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL]PYRROLIDINE-3-CARBONYL}PIPERAZIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S576-0944

Molecular Formula

C25H34N6O4 (C25 H34 N6 O4)

Compound Name

2-(4-{1-[1-(2-METHOXYETHYL)-6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL]PYRROLIDINE-3-CARBONYL}PIPERAZIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE

IUPAC name

n/a

SMILES

Cc(cc1)ccc1NC(CN(CC1)CCN1C(C(CC1)CN1C(C=NN1CCOC)=CC1=O)=O)=O

InChI

InChI=1S/C25H34N6O4/c1-19-3-5-21(6-4-19)27-23(32)18-28-9-11-29(12-10-28)25(34)20-7-8-30(17-20)22-15-24(33)31(26-16-22)13-14-35-2/h3-6,15-16,20H,7-14,17-18H2,1-2H3,(H,27,32)/t20-/m1/s1

InChI Key

HIDUBBCRFNFZDN-HXUWFJFHSA-N

MDL Number (MFCD)

MFCD29014964

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.352

Distribution Coefficient, logD

1.349

Water Solubility, LogSw

-2.35

Polar Surface Area

84.723

Acid Dissociation Constant (pKa)

12.46

Base Dissociation Constant (pKb)

5.22

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.00

S576-0944 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with S576-0944 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S576-0944?
Check Price and Availability of S576-0944, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S576-0944 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S576-0944
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S576-0944
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S576-0944 available by request